Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Hudson Executive Investment (HEC) Competitors

Hudson Executive Investment logo

HEC vs. INNV, DCGO, EUDA, PIII, KDLY, ATPC, VSEE, UPHL, BTTX, and LFST

Should you be buying Hudson Executive Investment stock or one of its competitors? The main competitors of Hudson Executive Investment include InnovAge (INNV), DocGo (DCGO), EUDA Health (EUDA), P3 Health Partners (PIII), Kindly MD (KDLY), Agape ATP (ATPC), Vsee Health (VSEE), UpHealth (UPHL), Better Therapeutics (BTTX), and LifeStance Health Group (LFST).

Hudson Executive Investment vs.

InnovAge (NASDAQ:INNV) and Hudson Executive Investment (NASDAQ:HEC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations, earnings, community ranking and media sentiment.

InnovAge and Hudson Executive Investment both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
InnovAgeOutperform Votes
No Votes
Underperform Votes
5
100.00%
Hudson Executive InvestmentN/AN/A

InnovAge has higher revenue and earnings than Hudson Executive Investment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InnovAge$763.85M0.66-$21.34M-$0.12-30.83
Hudson Executive InvestmentN/AN/A-$27.24MN/AN/A

InnovAge currently has a consensus target price of $6.00, indicating a potential upside of 62.16%. Given InnovAge's stronger consensus rating and higher possible upside, analysts clearly believe InnovAge is more favorable than Hudson Executive Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InnovAge
1 Sell rating(s)
2 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.67
Hudson Executive Investment
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, InnovAge had 2 more articles in the media than Hudson Executive Investment. MarketBeat recorded 2 mentions for InnovAge and 0 mentions for Hudson Executive Investment. InnovAge's average media sentiment score of 1.29 beat Hudson Executive Investment's score of 0.00 indicating that InnovAge is being referred to more favorably in the media.

Company Overall Sentiment
InnovAge Positive
Hudson Executive Investment Neutral

12.3% of InnovAge shares are owned by institutional investors. Comparatively, 73.4% of Hudson Executive Investment shares are owned by institutional investors. 1.4% of InnovAge shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Hudson Executive Investment has a net margin of 0.00% compared to InnovAge's net margin of -2.03%. InnovAge's return on equity of -5.68% beat Hudson Executive Investment's return on equity.

Company Net Margins Return on Equity Return on Assets
InnovAge-2.03% -5.68% -2.99%
Hudson Executive Investment N/A -337.48%-4.06%

Summary

InnovAge beats Hudson Executive Investment on 9 of the 11 factors compared between the two stocks.

Get Hudson Executive Investment News Delivered to You Automatically

Sign up to receive the latest news and ratings for HEC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HEC vs. The Competition

MetricHudson Executive InvestmentHealth Services IndustryMedical SectorNASDAQ Exchange
Market Cap$130.82M$942.44M$5.39B$9.24B
Dividend YieldN/A1.99%5.37%3.99%
P/E RatioN/A34.1789.1117.52
Price / SalesN/A3.751,229.3683.37
Price / CashN/A24.8243.6036.96
Price / Book26.332.875.014.72
Net Income-$27.24M-$3.49M$117.81M$224.61M

Hudson Executive Investment Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HEC
Hudson Executive Investment
N/A$3.16
+0.6%
N/A+31.9%$130.82MN/A0.00N/A
INNV
InnovAge
1.9357 of 5 stars
$3.57
-2.5%
$6.00
+68.1%
-34.6%$483.59M$763.85M-29.752,350News Coverage
Positive News
DCGO
DocGo
2.1109 of 5 stars
$4.17
-2.3%
$6.10
+46.3%
+27.6%$425.55M$624.29M14.894,164
EUDA
EUDA Health
0.8831 of 5 stars
$3.68
-3.2%
N/A+137.7%$90.64M$3.71M0.002
PIII
P3 Health Partners
2.3216 of 5 stars
$0.21
-4.8%
$2.38
+1,052.9%
-83.7%$73.92M$1.27B-0.25500High Trading Volume
KDLY
Kindly MD
N/A$1.47
+1.6%
N/AN/A$8.81MN/A0.00N/ANews Coverage
Positive News
Gap Down
ATPC
Agape ATP
0.1474 of 5 stars
$1.33
+3.9%
N/A-84.8%$5.31M$1.43M-1.8240
VSEE
Vsee Health
N/A$1.47
+4.3%
N/AN/A$5.29MN/A0.00N/APositive News
High Trading Volume
UPHL
UpHealth
N/A$0.00
-86.7%
N/A-99.9%$4,000.00$130M0.001,750Gap Down
BTTX
Better Therapeutics
N/AN/AN/AN/A$0.00N/A0.0040High Trading Volume
LFST
LifeStance Health Group
1.1592 of 5 stars
$7.99
+0.1%
$8.70
+8.9%
+12.7%$3.06B$1.06B-30.739,325Positive News

Related Companies and Tools


This page (NASDAQ:HEC) was last updated on 1/23/2025 by MarketBeat.com Staff
From Our Partners